Catherine Friedman is a financial industry expert with nearly 40 years of financial industry experience. Since 2006, she has been an independent financial consultant serving public and private companies in the life sciences industry. Previously, Ms. Friedman held numerous executive positions during a 23-year investment banking career with Morgan Stanley, including managing director, and head of West Coast Healthcare, and co-head of the Biotechnology Practice. Ms. Friedman is the chair of the board of directors for GRAIL, Inc. and also serves as a member of the boards of Altaba Inc. (formerly Yahoo! Inc.), Radius Health and Lyell Immunopharma, Inc. She is a trustee of The Darden School Foundation at the University of Virginia. Ms. Friedman holds a B.A. in economics from Harvard University and an MBA from The University of Virginia’s Darden School of Business.